Semaglutide and Vascular Regeneration

NCT05870462 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Obesity

Interventions

DRUG: Semaglutide Pen Injector

Sponsor

Canadian Medical and Surgical Knowledge Translation Research Group

Collaborators

[object Object]
[object Object]